Workforce shortages do not affect all patients equally. Rural communities face the greatest gaps in oncology access, with higher cancer mortality rates and longer travel times for treatment. Patients ...
Rising rates of breast cancer among working-age Australian women have prompted urgent calls for action to address the growing impact of financial ...
BREAKWATER trial Cohort 3 analysis demonstrated statistically significant and clinically meaningful improvement in ...
The colourful fruit and vegetables may help protect against certain cancers, according to an NHS Trust ...
Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that Itovebi® (inavolisib) is the first breast cancer therapy ...
In a previous press release dated 15 September 2025 [6], Crosetto had noted: ‘Most grants focus on recruitment and training ($2–5 million over five years). The High-Impact/High-Risk Research Awards ...
As Iowa’s rising cancer rates continue to generate discussion and concern among residents and politicians alike, the ...
ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe ...
HIGHLIGHTS Abstract outlining key findings from the Co-PSMA Investigator-Initiated Trial (IIT) has been released. The study was led by Prof Louise Emmett at St Vincent's Hospital Sydney, and the abstr ...
HIGHLIGHTS Abstract outlining key findings from the Co-PSMA Investigator-Initiated Trial (IIT) has been released. The study was led by Prof Louise Emmett at St Vincent's ...
Healthy eating advice shared by an NHS Trust explains why the colour is important in a balanced diet ...
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO beyond lung ...